Journal of the Korean Ophthalmological Society 2006;47(12):1960-1965.
Published online December 31, 2006.
Transscleral Diode Laser Photocoagulation for Retinopathy of Prematurity: Five Years' Experience.
Joon Woo Park, Hee Joon Cho, Young Wook Cho
Department of Ophthalmology Daegu Fatima Hospital, Daegu, Korea. ywcho2@kornet.net
미숙아망막병증에서 경공막 다이오드 레이저 광응고술의 5년간의 치료경험
박준우,조희준,조영욱
Department of Ophthalmology Daegu Fatima Hospital, Daegu, Korea
Correspondence:  Joon Woo Park, M.D.
Abstract
PURPOSE
S: We analysed the five-year outcomes and associated complications of transscleral diode laser photocoagulation (TSDLP), used to treat acute proliferative retinopathy of prematurity (ROP), to evaluate the efficacy and safety of this therapy. METHODS: We performed a retrospective analysis of the records of 163 eyes of 82 infants with acute ROP, who were treated with TSDLP by a single surgeon. Follow-up periods ranged from 15 to 278 weeks. RESULTS: The outcome was favorable in 158 eyes (96.9%) and unfavorable in 5 eyes (3.1%) of the 163 eyes that were treated. Vitreous hemorrhage was found to be an indicator of poor prognosis. Of the complications noted, symblepharon was observed in three eyes, hyphema was observed in four eyes, and a complicated cataract was observed in one eye. CONCLUSIONS: The results suggest that TSDLP is a safe and effective in the treatment of ROP. Vitreous hemorrhage should be regarded as a sign of poor prognosis.
Key Words: Transscleral diode laser photocoagulation;Vitreous hemorrhage;Retinopathy of prematurity


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next